ventricular tachypacing in dogs contributes to cardiac decompensation during chronic Altered expression of a limited number of genes

[1]  W. Jochum,et al.  Platelet-Derived Serotonin Mediates Liver Regeneration , 2006, Science.

[2]  Jian Cai,et al.  Metallothionein Disulfides Are Present in Metallothionein-overexpressing Transgenic Mouse Heart and Increase under Conditions of Oxidative Stress* , 2006, Journal of Biological Chemistry.

[3]  R. Tunin,et al.  Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure. , 2006, Journal of molecular and cellular cardiology.

[4]  A. Csiszar,et al.  Transcriptional basis for exercise limitation in male eNOS-knockout mice with age: heart failure and the fetal phenotype. , 2005, American journal of physiology. Heart and circulatory physiology.

[5]  S. Chittur,et al.  Genomic expression patterns of cardiac tissues from dogs with dilated cardiomyopathy. , 2005, American journal of veterinary research.

[6]  Vincenzo Lionetti,et al.  Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure. , 2005, Cardiovascular research.

[7]  F. Levy,et al.  Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  Mark Stitt,et al.  Real-time RT-PCR profiling of over 1400 Arabidopsis transcription factors: unprecedented sensitivity reveals novel root- and shoot-specific genes. , 2004, The Plant journal : for cell and molecular biology.

[9]  K. Becker,et al.  Gene expression profiling of oxidative stress on atrial fibrillation in humans , 2003, Experimental & Molecular Medicine.

[10]  Y. J. Kang,et al.  Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice. , 2003, The American journal of pathology.

[11]  M. Hori,et al.  Canine DNA array as a potential tool for combining physiology and molecular biology. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[12]  Hans Lehrach,et al.  Expression profiling of human idiopathic dilated cardiomyopathy. , 2003, Cardiovascular research.

[13]  L. Monassier,et al.  Overexpression of the Serotonin 5-HT2B Receptor in Heart Leads to Abnormal Mitochondrial Function and Cardiac Hypertrophy , 2003, Circulation.

[14]  Martin Vingron,et al.  Genome-Wide Array Analysis of Normal and Malformed Human Hearts , 2003, Circulation.

[15]  M. Le Cunff,et al.  Transcriptomal analysis of failing and nonfailing human hearts. , 2003, Physiological genomics.

[16]  M. Farrer,et al.  Case‐Control study of dopamine transporter‐1, monoamine oxidase‐B, and catechol‐O‐methyl transferase polymorphisms in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[17]  Jianbo Li,et al.  The gene expression fingerprint of human heart failure , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  William C Stanley,et al.  Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-&agr; in Pacing-Induced Heart Failure , 2002, Circulation.

[19]  George C Tseng,et al.  Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. , 2002, Physiological genomics.

[20]  Paul D Allen,et al.  Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. , 2002, The American journal of pathology.

[21]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[22]  J. Vonesch,et al.  Ablation of Serotonin 5-HT2B Receptors in Mice Leads to Abnormal Cardiac Structure and Function , 2001, Circulation.

[23]  Y. J. Kang,et al.  Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart. , 2001, Cancer research.

[24]  L. Hawthorn,et al.  Decreased SLIM1 Expression and Increased Gelsolin Expression in Failing Human Hearts Measured by High-Density Oligonucleotide Arrays , 2000, Circulation.

[25]  Elias S. J. Arnér,et al.  Physiological functions of thioredoxin and thioredoxin reductase. , 2000, European journal of biochemistry.

[26]  L. Stanton,et al.  Altered patterns of gene expression in response to myocardial infarction. , 2000, Circulation research.

[27]  P. Armstrong,et al.  Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure. , 1999, Cardiovascular research.

[28]  F. Recchia,et al.  Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. , 1998, Circulation research.

[29]  E. Cadenas,et al.  The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA. , 1996, Archives of biochemistry and biophysics.

[30]  M. Matsui,et al.  Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. , 1996, Developmental biology.

[31]  L. Ernster,et al.  Hydrogen peroxide production by monoamine oxidase in isolated rat-brain mitochondria: its effect on glutathione levels and Ca2+ efflux. , 1990, Biochimica et biophysica acta.